These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 32792482)

  • 1. A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR.
    Liu H; Xu Y; Yao B; Sui T; Lai L; Li Z
    Cell Death Dis; 2020 Aug; 11(8):613. PubMed ID: 32792482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
    Hu N; Ji H
    Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer.
    Lu S; Han L; Hu X; Sun T; Xu D; Li Y; Chen Q; Yao W; He M; Wang Z; Wu H; Wei M
    J Hematol Oncol; 2021 Nov; 14(1):188. PubMed ID: 34743750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential.
    Yang D; Qiao J; Wang G; Lan Y; Li G; Guo X; Xi J; Ye D; Zhu S; Chen W; Jia W; Leng Y; Wan X; Kang J
    Nucleic Acids Res; 2018 May; 46(8):3906-3920. PubMed ID: 29529255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
    Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
    Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
    Zhang S; Shao Y; Li D; Li C
    Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
    Qian X; Yang J; Qiu Q; Li X; Jiang C; Li J; Dong L; Ying K; Lu B; Chen E; Liu P; Lu Y
    J Hematol Oncol; 2021 Jul; 14(1):112. PubMed ID: 34274028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis.
    Liu H; Liang J; Dai X; Peng Y; Xiong W; Zhang L; Li X; Li W; Liu K; Bi S; Wang X; Zhang W; Liu Y
    Genomics; 2024 Mar; 116(2):110803. PubMed ID: 38290592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
    Wen S; Wei Y; Zen C; Xiong W; Niu Y; Zhao Y
    Mol Cancer; 2020 Dec; 19(1):171. PubMed ID: 33308223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p.
    Hu Y; Tang J; Xu F; Chen J; Zeng Z; Han S; Wang F; Wang D; Huang M; Zhao Y; Huang Y; Zhuo W; Zhao G
    J Exp Clin Cancer Res; 2022 Feb; 41(1):69. PubMed ID: 35183226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YTHDF1 facilitates esophageal cancer progression via augmenting m6A-dependent TINAGL1 translation.
    Zhang L; Cai E; Xu Y; Liu Z; Zheng M; Sun Z; Pei D; Wang Q
    Cell Signal; 2024 Oct; 122():111332. PubMed ID: 39098703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
    Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
    Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
    Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
    Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N
    Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H
    Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive analysis of lncRNAs N
    Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
    Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
    Shang Y
    Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.